Related Experiment Video

Updated: Feb 17, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

730

Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol

E M C Driessen, P de Lorenzo, M Campbell

    Leukemia
    |December 7, 2017
    PubMed

    Abstract:

    This corrects the article DOI: 10.1038/leu.2015.246.

    More Related Videos

    Rapid in vivo Drug Response Prediction Using Leukemia Cell Grafts in Zebrafish Embryos
    10:46

    Rapid in vivo Drug Response Prediction Using Leukemia Cell Grafts in Zebrafish Embryos

    Published on: May 23, 2025

    985
    Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
    09:57

    Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

    Published on: March 5, 2018

    30.7K

    Related Experiment Videos

    Last Updated: Feb 17, 2026

    Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
    08:31

    Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

    Published on: October 17, 2025

    730
    Rapid in vivo Drug Response Prediction Using Leukemia Cell Grafts in Zebrafish Embryos
    10:46

    Rapid in vivo Drug Response Prediction Using Leukemia Cell Grafts in Zebrafish Embryos

    Published on: May 23, 2025

    985
    Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
    09:57

    Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

    Published on: March 5, 2018

    30.7K

    Related Concept Videos

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    3.8K
    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    3.8K

    Articles linked to this work by shared authors, journal, and citation graph.

    Multidisciplinary consensus-based statement on the current role of middle meningeal artery embolization (MMAE) in chronic SubDural hematoma (cSDH).

    Brain & spine·2024

    Investigating cortical excitability and inhibition in patients with schizophrenia: A TMS-EEG study.

    Brain research bulletin·2024

    Functional outcomes after transanal total mesorectal excision (TaTME): a random forest analysis to predict patients' outcomes.

    Techniques in coloproctology·2023

    Surgical or Endovascular Treatment of MCA Aneurysms: An Agreement Study.

    AJNR. American journal of neuroradiology·2022

    Open versus laparoscopic gastrectomy for advanced gastric cancer: a propensity score matching analysis of survival in a western population-on behalf of the Italian Research Group for Gastric Cancer.

    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·2022

    From mothership to drip-and-ship: Effects of staff shortages at a comprehensive stroke center.

    Revue neurologique·2022

    mTORC1 inhibition upregulates CD20 and enhances anti-CD20 antibody efficacy in B-cell precursor acute lymphoblastic leukemia.

    Leukemia·2026

    A novel role for transcription factor NFE2 in redox regulation and chemotherapy resistance in acute myeloid leukemia.

    Leukemia·2026

    Immunotherapeutic targeting of calreticulin mutant myeloproliferative neoplasms.

    Leukemia·2026

    A role for the protease MALT1 in EBV-mediated B-cell transformation by Latent Membrane Proteins 1 and 2.

    Leukemia·2026

    USP8 controls proteostasis pathways in B cells and multiple myeloma.

    Leukemia·2026

    The FOLR2-IRF2BP2 axis mediates erythropoiesis impairment by excess folic acid in myelodysplastic neoplasms.

    Leukemia·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us